Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06481176

Blood Changes After Exercise in Restless Legs Syndrome

Proteomic Response to Exercise in Adults With Restless Legs Syndrome

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn how exercise changes molecules in the blood in people with restless legs syndrome (RLS) to better understand the cause(s) of RLS. The main questions the investigators aim to answer are: How does long-term exercise change proteins in the blood? How does a single exercise session change proteins in the blood? The investigators will compare long-term exercise to no exercise to see if the changes in proteins are specific to exercise. Participants will complete an exercise test and provide blood samples before and after the exercise test. Participants will be randomized (like the flip of a coin) in to either the exercise or no-exercise group for 12 weeks and then complete the exercise test and blood samples again at the end.

Conditions

Interventions

TypeNameDescription
BEHAVIORAL12-Week RLS Exercise ProgramParticipants will complete 12 weeks of an evidence-based exercise program that has been used for people with RLS, designed for people with RLS, and was informed by exercise guidelines outlined by the American College of Sports Medicine (ACSM) and the American Heart Association, and Center for Disease Control. The program includes three sessions per week for 12 weeks including: * cardiovascular exercise (e.g., walking/jogging, bicycling) for 30 minutes/day on at least 3 days/week at a moderate-to-vigorous intensity * strength training on 2 non-consecutive days/week targeting major muscle groups for approximately 30 minutes * Stretching all major muscle groups on three or more days per week

Timeline

Start date
2024-10-21
Primary completion
2026-08-01
Completion
2026-12-01
First posted
2024-07-01
Last updated
2024-11-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06481176. Inclusion in this directory is not an endorsement.